These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29714616)

  • 1. Evaluation of Risk Versus Benefit Information in Direct-To-Consumer (DTC) Prescription Drug Television Advertisements.
    Fahim G; Toscani M; Barone JA; Wang C; Gandhi S
    Ther Innov Regul Sci; 2018 Jan; 52(1):114-117. PubMed ID: 29714616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Including Quantitative Information on Multiple Endpoints in Direct-to-Consumer Prescription Drug Television Advertisements.
    Sullivan HW; O'Donoghue AC; Lynch M; Johnson M; Davis C; Rupert DJ
    Med Decis Making; 2019 Nov; 39(8):975-985. PubMed ID: 31583947
    [No Abstract]   [Full Text] [Related]  

  • 3. Serious and actionable risks, plus disclosure: Investigating an alternative approach for presenting risk information in prescription drug television advertisements.
    Betts KR; Boudewyns V; Aikin KJ; Squire C; Dolina S; Hayes JJ; Southwell BG
    Res Social Adm Pharm; 2018 Oct; 14(10):951-963. PubMed ID: 28844621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis.
    Adams C
    J Med Internet Res; 2016 Feb; 18(2):e33. PubMed ID: 26892749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay.
    Aikin KJ; Southwell BG; Paquin RS; Rupert DJ; O'Donoghue AC; Betts KR; Lee PK
    Res Social Adm Pharm; 2017; 13(2):378-388. PubMed ID: 27178746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual presentations of efficacy data in direct-to-consumer prescription drug print and television advertisements: A randomized study.
    Sullivan HW; O'Donoghue AC; Aikin KJ; Chowdhury D; Moultrie RR; Rupert DJ
    Patient Educ Couns; 2016 May; 99(5):790-9. PubMed ID: 26749356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters.
    Kim H
    Int J Health Policy Manag; 2015 Aug; 4(12):813-21. PubMed ID: 26673465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consumer responses to framing statements preceding the major risk statement in prescription drug DTC TV ads.
    Aikin KJ; Betts KR; Boudewyns V; Johnson M; Davis CN
    Res Social Adm Pharm; 2020 Sep; 16(9):1237-1247. PubMed ID: 31838056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Updated Analysis of Direct-to-Consumer Television Advertisements for Prescription Drugs.
    Applequist J; Ball JG
    Ann Fam Med; 2018 May; 16(3):211-216. PubMed ID: 29760024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cross-media content analysis of motivational themes in direct-to-consumer prescription drug advertising.
    Sumpradit N; Ascione FJ; Bagozzi RP
    Clin Ther; 2004 Jan; 26(1):135-54. PubMed ID: 14996526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct-to-consumer promotion of prescription drugs. Economic implications for patients, payers and providers.
    Findlay SD
    Pharmacoeconomics; 2001; 19(2):109-19. PubMed ID: 11284378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of Narratives to Deliver Information in Direct-To-Consumer Prescription Drug Commercials: A Content Analysis.
    Ball JG; Applequist J
    J Health Commun; 2019; 24(5):512-524. PubMed ID: 31256712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of presentation modality in direct-to-consumer (DTC) prescription drug television advertisements.
    Wogalter MS; Shaver EF; Kalsher MJ
    Appl Ergon; 2014 Sep; 45(5):1330-6. PubMed ID: 24377979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Communicating Risk Information in Direct-to-Consumer Prescription Drug Television Ads: A Content Analysis.
    Sullivan HW; Aikin KJ; Poehlman J
    Health Commun; 2019 Feb; 34(2):212-219. PubMed ID: 29125325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in exposure to televised prescription drug advertising, 2003-2011.
    Kornfield R; Alexander GC; Qato DM; Kim Y; Hirsch JD; Emery SL
    Am J Prev Med; 2015 May; 48(5):575-9. PubMed ID: 25891057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Now you see it. Now you don't: fair balance and adequate provision in advertisements for drugs before and after the switch from prescription to over-the-counter.
    Faerber AE; Kreling DH
    Health Commun; 2012; 27(1):66-74. PubMed ID: 21745037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintaining a Fair Balance? Narrative and Non-Narrative Strategies in Televised Direct-to-Consumer Advertisements for Prescription Drugs Aired in the United States, 2003-2016.
    Liu J; Avery RJ; Kim JJ; Niederdeppe J
    J Health Commun; 2022 Mar; 27(3):183-191. PubMed ID: 35593131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual- and Ad-Level Predictors of Perceptions of Serious and Actionable Risks in Direct-to-Consumer Prescription Drug TV Advertising.
    Aikin KJ; Boudewyns V; Betts KR; Southwell BG; Williams P
    J Health Commun; 2019; 24(5):536-546. PubMed ID: 31253071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Content analysis of false and misleading claims in television advertising for prescription and nonprescription drugs.
    Faerber AE; Kreling DH
    J Gen Intern Med; 2014 Jan; 29(1):110-8. PubMed ID: 24030427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do dissonant ad visuals cause consumers to discount prescription drug side effects?
    Hagenbuch D
    Health Mark Q; 2019; 36(4):337-353. PubMed ID: 31646956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.